![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](gg2070contents.gif)
Acta Cryst. (2012). E68, o147 [ doi:10.1107/S1600536811053487 ]
Abstract: The title compound, C9H12ClN4+·Cl-, is a natural metabolic product of imidacloprid [systematic name: (E)-1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine] and was obtained by the reduction of the latter using Fe in HCl. The dihedral angle between the pyridine and imidazole rings is 62.09 (12)°. The crystal structure is stabilized by N-H
Cl and C-H
Cl interactions involving the chloride anion. The pyridine N and the chloride atoms are not involved in intermolecular interactions.
Online 17 December 2011
Copyright © International Union of Crystallography
IUCr Webmaster